💰ソブリン・ウェルス・ファンド
GIC Invests in Hua Medicine
Shanghai-based Hua Medicine raised a combined US$ 117.4 million in Series D & Series E rounds.
Hua Medicine is a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes.
SWFI – Sovereign Wealth Fund Institute
https://www.swfinstitute.org/swf-news/gic-invests-in-hua-medicine/